Segment Wealth Management LLC Sells 45 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Segment Wealth Management LLC lessened its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,052 shares of the medical equipment provider’s stock after selling 45 shares during the quarter. Segment Wealth Management LLC’s holdings in Intuitive Surgical were worth $2,637,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently made changes to their positions in ISRG. AE Wealth Management LLC grew its position in shares of Intuitive Surgical by 24.5% during the 2nd quarter. AE Wealth Management LLC now owns 3,822 shares of the medical equipment provider’s stock valued at $1,700,000 after acquiring an additional 752 shares during the period. Epoch Investment Partners Inc. lifted its holdings in Intuitive Surgical by 7.1% in the 2nd quarter. Epoch Investment Partners Inc. now owns 1,036 shares of the medical equipment provider’s stock worth $461,000 after purchasing an additional 69 shares in the last quarter. Fidelis Capital Partners LLC grew its stake in Intuitive Surgical by 5.3% during the second quarter. Fidelis Capital Partners LLC now owns 2,438 shares of the medical equipment provider’s stock valued at $1,095,000 after acquiring an additional 123 shares in the last quarter. EverSource Wealth Advisors LLC grew its position in shares of Intuitive Surgical by 32.1% during the second quarter. EverSource Wealth Advisors LLC now owns 1,157 shares of the medical equipment provider’s stock valued at $514,000 after purchasing an additional 281 shares in the last quarter. Finally, Edge Capital Group LLC increased its stake in Intuitive Surgical by 6.3% in the 2nd quarter. Edge Capital Group LLC now owns 744 shares of the medical equipment provider’s stock worth $331,000 after acquiring an additional 44 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently issued reports on ISRG. Citigroup raised their price objective on Intuitive Surgical from $567.00 to $640.00 and gave the company a “buy” rating in a research note on Wednesday, December 11th. The Goldman Sachs Group set a $604.00 target price on Intuitive Surgical in a research report on Friday, October 18th. Raymond James upped their price target on shares of Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a report on Monday, October 14th. Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Finally, Stifel Nicolaus upped their target price on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research note on Thursday, December 5th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $554.17.

Insider Transactions at Intuitive Surgical

In other news, insider Jamie Samath sold 269 shares of the company’s stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $539.89, for a total transaction of $145,230.41. Following the completion of the sale, the insider now owns 8,757 shares in the company, valued at approximately $4,727,816.73. This represents a 2.98 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Gary S. Guthart sold 18,151 shares of the business’s stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the transaction, the chief executive officer now directly owns 24,219 shares in the company, valued at $12,391,166.97. This trade represents a 42.84 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 43,509 shares of company stock worth $22,602,212. Company insiders own 0.80% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock opened at $592.64 on Tuesday. The firm’s 50-day simple moving average is $540.66 and its 200-day simple moving average is $499.64. Intuitive Surgical, Inc. has a 1 year low of $362.14 and a 1 year high of $597.68. The firm has a market cap of $211.09 billion, a PE ratio of 95.28, a price-to-earnings-growth ratio of 5.04 and a beta of 1.39.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.